Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-15-020232
Filing Date
2015-03-31
Accepted
2015-03-31 17:02:27
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v405650_10k.htm 10-K 1209852
2 EXHIBIT 21.1 v405650_ex21-1.htm EX-21.1 1528
3 EXHIBIT 23.1 v405650_ex23-1.htm EX-23.1 3200
4 EXHIBIT 31.1 v405650_ex31-1.htm EX-31.1 6840
5 EXHIBIT 32.1 v405650_ex32-1.htm EX-32.1 4254
6 GRAPHIC tpg01.jpg GRAPHIC 51307
7 GRAPHIC tpg12.jpg GRAPHIC 68500
8 GRAPHIC tpg13.jpg GRAPHIC 36471
9 GRAPHIC tpg14.jpg GRAPHIC 52888
10 GRAPHIC tpg18a.jpg GRAPHIC 42329
11 GRAPHIC tpg18b.jpg GRAPHIC 24676
12 GRAPHIC tpg18c.jpg GRAPHIC 22641
  Complete submission text file 0001144204-15-020232.txt   1639346
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36672 | Film No.: 15740102
SIC: 2834 Pharmaceutical Preparations